Sam Carter
 | This article is a stub. |
Sam Carter (Samuel Carter) is an advocate and a patient with myalgic encephalomyelitis.
Talks and interviews[edit | edit source]
Letters[edit | edit source]
- 2010 - FINE trial for CFS. Both significant and small?[1]
- 2012 - A valedictory dispatch from the Psychosocial School?[2]
- 2016 - Exploring changes to PACE trial outcome measures using anonymised data from the FINE trial[3]
Online presence[edit | edit source]
- Website/Blog
- YouTube
See also[edit | edit source]
Learn more[edit | edit source]
- Wikipedia
References[edit | edit source]
- ↑ Carter, Sam (Jun 9, 2010). "FINE Trial for CFS: Both significant and small?". BMJ. 340: c2988. doi:10.1136/bmj.c2988. ISSN 0959-8138. PMID 20534659.
- ↑ Carter, Sam (May 5, 2012). "A valedictory dispatch from the Psychosocial School? | Rapid Responses to articles". BMJ. Retrieved Jan 29, 2019.
- ↑ Carter, Sam (Feb 15, 2016). "Exploring changes to PACE trial outcome measures using anonymised data from the FINE trial". PubMed Commons.
BMJ - The BMJ (previously the British Medical Journal) is a weekly peer-reviewed medical journal.
The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.
